Knockdown of Long Non-Coding RNA HCP5 Increases Radiosensitivity Through Cellular Senescence by Regulating microRNA-128 in Gliomas

References

• Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284–297. doi:10.1007/s13311-017-0519-x28281173
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–1068. doi:10.1038/nature0738518772890
   PubMed Web of Science ®Google Scholar
• Homma T, Fukushima T, Vaccarella S, et al. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol. 2006;65(9):846–854. doi:10.1097/01.jnen.0000235118.75182.9416957578
   PubMed Web of Science ®Google Scholar
• Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N, Antiangiogenic therapy for high-grade glioma. Cochrane Database Syst Rev. 2014;9:CD008218. doi:10.1002/14651858.CD008218.pub325242542
   PubMed Web of Science ®Google Scholar
• Deng G, Sui G. Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci. 2013;14(9):18319–18349. doi:10.3390/ijms14091831924013378
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.00619239885
   PubMed Web of Science ®Google Scholar
• Teppan J, Barth DA, Prinz F, Jonas K, Pichler M, Klec C. Involvement of long non-coding RNAs (lncRNAs) in tumor angiogenesis. Noncoding RNA. 2020;6(4):52.
   Web of Science ®Google Scholar
• Egranov SD, Hu Q, Lin C, Yang L. LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy. RNA Biol. 2020;17(11):1625–1627. doi:10.1080/15476286.2020.176745532449433
   PubMed Web of Science ®Google Scholar
• Lu W, Cao F, Wang S, Sheng X, Ma J. LncRNAs: the regulator of glucose and lipid metabolism in tumor cells. Front Oncol. 2019;9:1099. doi:10.3389/fonc.2019.0109931850189
   PubMed Web of Science ®Google Scholar
• Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of MiR-128-3p/GREM1 axis and BMP signaling pathway. Neurotherapeutics. 2018;15(4):1139–1157. doi:10.1007/s13311-018-0649-930120709
   PubMed Web of Science ®Google Scholar
• Li XT, Li JC, Feng M, Zhou YX, Du ZW. Novel lncRNA-ZNF281 regulates cell growth, stemness and invasion of glioma stem-like U251s cells. Neoplasma. 2019;66(1):118–127. doi:10.4149/neo_2018_180613N39130509101
   PubMed Web of Science ®Google Scholar
• Wang P, Liu YH, Yao YL, et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 2015;27(2):275–282. doi:10.1016/j.cellsig.2014.11.01125446261
   PubMed Web of Science ®Google Scholar
• Cai H, Xue Y, Wang P, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6(23):19759–19779. doi:10.18632/oncotarget.433126078353
   PubMedGoogle Scholar
• Hu YW, Kang CM, Zhao JJ, et al. LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1. J Cell Mol Med. 2018;22(1):497–510. doi:10.1111/jcmm.1333828922548
   PubMed Web of Science ®Google Scholar
• Yao Y, Ma J, Xue Y, et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 2015;359(1):75–86. doi:10.1016/j.canlet.2014.12.05125578780
   PubMed Web of Science ®Google Scholar
• Wang C, Chen Y, Wang Y, et al. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J Exp Clin Cancer Res. 2019;38(1):371. doi:10.1186/s13046-019-1361-231438982
   PubMed Web of Science ®Google Scholar
• Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4(3):e1000041. doi:10.1371/journal.pgen.100004118369459
   PubMed Web of Science ®Google Scholar
• Kulski JK. Long noncoding RNA HCP5, a hybrid HLA Class I endogenous retroviral gene: structure, expression, and disease associations. Cells. 2019;8(5). doi:10.3390/cells8050480
   Web of Science ®Google Scholar
• Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a. Eur Rev Med Pharmacol Sci. 2018;22(15):4812–4819. doi:10.26355/eurrev_201808_1561630070314
   PubMed Web of Science ®Google Scholar
• Hu R, Lu Z. Long noncoding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR4656 to modulate CEMIP expression. Oncol Rep. 2020;43(1):328–336. doi:10.3892/or.2019.740431746434
   PubMed Web of Science ®Google Scholar
• Zhao C, Li Y, Hu X, et al. LncRNA HCP5 promotes cell invasion and migration by sponging miR-29b-3p in human bladder cancer. Onco Targets Ther. 2020;13:11827–11838. doi:10.2147/OTT.S24977033235469
   PubMed Web of Science ®Google Scholar
• Liang L, Xu J, Wang M, et al. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. Cell Death Dis. 2018;9(3):372. doi:10.1038/s41419-018-0382-729515098
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao D, Meng Q. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer. Biomed Pharmacother. 2019;116:108966. doi:10.1016/j.biopha.2019.10896631102936
   PubMed Web of Science ®Google Scholar
• Wu J, Chen H, Ye M, et al. Corrigendum to “Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression” [Biomed. Pharmacother. 115 (2019) 108869]. Biomed Pharmacother. 2020;122:109789. doi:10.1016/j.biopha.2019.10978931864836
   PubMed Web of Science ®Google Scholar
• Liu N, Zhang R, Zhao X, et al. A potential diagnostic marker for ovarian cancer: involvement of the histone acetyltransferase, human males absent on the first. Oncol Lett. 2013;6(2):393–400. doi:10.3892/ol.2013.138024137335
   PubMed Web of Science ®Google Scholar
• Lange CM, Bibert S, Dufour JF, et al. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol. 2013;59(3):504–509. doi:10.1016/j.jhep.2013.04.03223665287
   PubMed Web of Science ®Google Scholar
• Teng H, Wang P, Xue Y, et al. Role of HCP5-miR-139-RUNX1 feedback loop in regulating malignant behavior of glioma cells. Mol Ther. 2016;24(10):1806–1822. doi:10.1038/mt.2016.10327434586
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Tumilson CA, Lea RW, Alder JE, Shaw L. Circulating microRNA biomarkers for glioma and predicting response to therapy. Mol Neurobiol. 2014;50(2):545–558. doi:10.1007/s12035-014-8679-824696266
   PubMed Web of Science ®Google Scholar
• Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Regulation of miRNA expression during neural cell specification. Eur J Neurosci. 2005;21(6):1469–1477. doi:10.1111/j.1460-9568.2005.03978.x15845075
   PubMed Web of Science ®Google Scholar
• Persengiev SP, Kondova II, Bontrop RE. The impact of MicroRNAs on brain aging and neurodegeneration. Curr Gerontol Geriatr Res. 2012;2012:359369. doi:10.1155/2012/35936922312330
   PubMedGoogle Scholar
• Sun J, Ye L, Wang C, Li N, Wang D, Li X. MicroRNA-128 increases glioma cell radio-sensitivity by suppressing senescent evasion through oncogene Bmi-1. Int J Clin Exp Pathol. 2018;11(3):1423–1430.31938239
   PubMed Web of Science ®Google Scholar
• Ye L, Yu G, Wang C, et al. MicroRNA128a, BMI1 polycomb ring finger oncogene, and reactive oxygen species inhibit the growth of U87 MG glioblastoma cells following exposure to Xray radiation. Mol Med Rep. 2015;12(4):6247–6254. doi:10.3892/mmr.2015.417526238021
   PubMed Web of Science ®Google Scholar
• Ye L, Wang C, Yu G, et al. Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells. Oncol Lett. 2014;8(6):2601–2606. doi:10.3892/ol.2014.260625364434
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363–9367. doi:10.1073/pnas.92.20.93637568133
   PubMed Web of Science ®Google Scholar
• Huo L, Wang B, Zheng M, et al. miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway. Exp Ther Med. 2019;17(4):2921–2930. doi:10.3892/etm.2019.728430906475
   PubMed Web of Science ®Google Scholar
• Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166–193. doi:10.3322/caac.2006920445000
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-020922096659
   PubMed Web of Science ®Google Scholar
• Renganathan A, Felley-Bosco E. Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199–222.28815541
   PubMed Web of Science ®Google Scholar
• Fu D, Shi Y, Liu JB, et al. Targeting long non-coding RNA to therapeutically regulate gene expression in cancer. Mol Ther Nucleic Acids. 2020;21:712–724. doi:10.1016/j.omtn.2020.07.00532771923
   PubMedGoogle Scholar
• Choudhari R, Sedano MJ, Harrison AL, et al. Long noncoding RNAs in cancer: from discovery to therapeutic targets. Adv Clin Chem. 2020;95:105–147.32122521
   PubMed Web of Science ®Google Scholar
• Peng Z, Liu C, Wu M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018;17(1):61. doi:10.1186/s12943-018-0812-229458374
   PubMed Web of Science ®Google Scholar
• Chen S, Ren C, Zheng H, Sun X, Dai J. The effect of long non-coding RNA (lncRNA) HCP5 on regulating epithelial-mesenchymal transition (EMT)-related markers in gastric carcinoma is partially reversed by miR-27b-3p. Med Sci Monit. 2020;26:e921383.32357145
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718. doi:10.1136/jmedgenet-2015-10333426358722
   PubMed Web of Science ®Google Scholar
• Ergun S, Oztuzcu S. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol. 2015;36(5):3129–3136. doi:10.1007/s13277-015-3346-x25809705
   PubMedGoogle Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature1298624429633
   PubMed Web of Science ®Google Scholar
• Wu Y, Qian Z. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma. Discov Med. 2019;28(153):129–138.31926584
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang L, Zhang X, et al. LncRNA HCP5 promotes neuroblastoma proliferation by regulating miR-186-5p/MAP3K2 signal axis. J Pediatr Surg. 2020. doi:10.1016/j.jpedsurg.2020.10.011
   Web of Science ®Google Scholar
• Zhao J, Bai X, Feng C, Shang X, Xi Y. Long non-coding RNA HCP5 facilitates cell invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by miR-140-5p/SOX4 axis. Cancer Manag Res. 2019;11:10455–10462. doi:10.2147/CMAR.S23032431849534
   PubMed Web of Science ®Google Scholar
• Wang L, Luan T, Zhou S, et al. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(9):4389–4403. doi:10.1002/cam4.233531215169
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang J, Dong L, et al. Long noncoding RNA HCP5 regulates pancreatic cancer gemcitabine (GEM) resistance by sponging Hsa-miR-214-3p to target HDGF. Onco Targets Ther. 2019;12:8207–8216. doi:10.2147/OTT.S22270331632071
   PubMed Web of Science ®Google Scholar
• Chen R, Xin G, Zhang X. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway. J Pediatr Endocrinol Metab. 2019;32(12):1327–1339. doi:10.1515/jpem-2018-043231622249
   PubMed Web of Science ®Google Scholar
• Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334(4):1351–1358. doi:10.1016/j.bbrc.2005.07.03016039986
   PubMed Web of Science ®Google Scholar
• Godlewski J, Nowicki MO, Bronisz A, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008;68(22):9125–9130. doi:10.1158/0008-5472.CAN-08-262919010882
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chao T, Li R, et al. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med. 2009;87(1):43–51. doi:10.1007/s00109-008-0403-618810376
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhi F, Peng Y, Yang CC. MiR-128 promotes the apoptosis of glioma cells via binding to NEK2. Eur Rev Med Pharmacol Sci. 2018;22(24):8781–8788. doi:10.26355/eurrev_201812_1664530575919
   PubMed Web of Science ®Google Scholar
• Shang C, Hong Y, Guo Y, Liu YH, Xue YX. miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE. Oncol Lett. 2016;11(1):904–908. doi:10.3892/ol.2015.392726870304
   PubMed Web of Science ®Google Scholar
• She X, Yu Z, Cui Y, et al. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. Oncol Rep. 2014;32(3):957–964. doi:10.3892/or.2014.331825017996
   PubMed Web of Science ®Google Scholar
• Shan ZN, Tian R, Zhang M, et al. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Oncotarget. 2016;7(48):78813–78826. doi:10.18632/oncotarget.1238527705931
   PubMedGoogle Scholar
• Tu Y, Gao X, Li G, et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013;73(19):6046–6055. doi:10.1158/0008-5472.CAN-13-035823950210
   PubMed Web of Science ®Google Scholar
• Peruzzi P, Bronisz A, Nowicki MO, et al. MicroRNA-128 coordinately targets polycomb repressor complexes in glioma stem cells. Neuro Oncol. 2013;15(9):1212–1224. doi:10.1093/neuonc/not05523733246
   PubMed Web of Science ®Google Scholar